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Abstract
Matrix-Assisted Laser Desorption and Ionization Time-of-Flight Mass
Spectrometry (MALDI-TOF MS) has been revealed as an invaluable platform for
identifying anaerobic bacteria in the clinical laboratory over traditional methods such as
the RapID ANA II System.
A qualitative comparison is made, through the analysis of methodologies and
specifications, to determine whether the RapID ANA II system or Bruker MALDI-TOF
MS is more suitable for identifying anaerobic organism in the clinical laboratory. Based
on the data reviewed, the MALDI-TOF MS is a more intuitive platform within the clinical
laboratory due to its increased specificity, cost-effectiveness, and shorten turnaround
time for the identification of anaerobes.
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Introduction
Anaerobic bacteria grow in the absence of oxygen. The major types of
anaerobes are obligate anaerobes, facultative anaerobes, and aerotolerant anaerobes.
Obligate anaerobes only grow in the absence of oxygen. Facultative anaerobes do not
require oxygen to grow but will use it if available. Aerotolerant anaerobes grow best
without oxygen but can tolerate its presence. Anaerobes are part of the normal flora
found on the human body. Under normal circumstances, anaerobic bacteria live on the
body as beneficial commensals. The major sources of anaerobes are situated in the
mouth, mucosal membrane surfaces, gastrointestinal and genital tracts.[1]
Prevotella and Peptostreptococcus species, which are part of our normal
anaerobic gram-negative and gram-positive oral flora, have characteristics to protect the
human body. [2] In a study conducted on children with a history of group A β-hemolytic
streptococci (GABHS) pharyngotonsillitis, children with less Prevotella and
Peptostreptococcus anaerobes cultured from their tonsils have an increased likelihood
of having recurring GABHS infections than children with more of these anaerobes.[2]
This phenomenon is known as bacterial interference and colonization resistance.

[2,3]

However, in humans with immunocompromised status, trauma or disease, GABHS
infections may lead to serious anaerobic infections or death. [3] Therefore, it is
imperative that the laboratory can identify anaerobes accurately and timely.
A specimen must be obtained before anaerobes can be identified. Due to the
fastidious nature of anaerobes, it is often difficult to culture and grow them if collection
techniques are not properly followed. [4] Some anaerobes are killed within seconds once
they encounter molecular oxygen. [5] Therefore, using proper collection techniques is
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important to enhance anaerobic growth with better outcomes. When anaerobes are
stored in room temperature with the appropriate anaerobic transport tube, anaerobes
will survive 24 to 72 hours. However, the survival of certain species of anaerobes is
greatly diminished after 48 hours. [5] As a result, the ability to rapidly identify the correct
type of anaerobic bacteria is extremely important when treating patients with anaerobic
infections.
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Methods
Given the need for the rapid identification of anaerobes, different tools have been
developed to aid laboratorians in identifying anaerobes. The “golden standard” for
identifying bacterial species is using whole-genome sequencing (WGS) and 16S
ribosomal ribonucleic acid (rRNA) gene sequencing. [6,7] However, due to the cost and
lengthy turnaround time of sequencing, these two methods are not the ideal options for
identifying anaerobes in the clinical laboratory. At present, Remel RapID ANA II and the
Bruker MALDI-TOF MS appear to be the most commonly used methods in anaerobic
identification. A qualitative comparison is conducted to determine which of these two
methods is more desirable for identifying anaerobic organism in the clinical laboratory
via thorough analysis of their methodologies and specifications.

Remel RapID ANA II System
The Remel RapID ANA II system is a chromogenic, single sub-substrate
qualitative method using enzyme technology tests to identify clinically significant
anaerobes from human specimens. The assay is comprised of a plastic disposable
RapID panel with ten reaction cavities, RapID inoculation fluid, RapID ANA II reagent,
and RapID Spot Indole reagent. The test organism must first be dispensed into the
RapID inoculation fluid prior to the inoculation of the cavity. After the inoculation of the
panel, the organism must be incubated for 4-6 hours. Upon the completion of
incubation, reagents must be added into underlined wells to produce a colorimetric
change which indicates the presence of enzymes. The resulting pattern must then be
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entered into an Electronic RapID Compendium (ERIC) database used to identify the
anaerobic bacteria.[8]

Matrix-Assisted Laser Desorption and Ionization (MALDI) System
The MALDI is an ionization technique that uses a matrix to form ions from larger
molecules for molecular identification. [11] First, the user must transfer a bacterial colony
grown from a patient sample (which is first mixed with or without formic acid depending
on the organism being identified) onto a MALDI “target” plate. The bacterial isolate is
then embedded with the matrix for protein extraction. [12,13] Figure 1 below depicts the
preparation of a sample plate for sample analysis (Clark et al., 2013). After the isolate
embedded with the matrix is dried, the plate is inserted into the ionization assembly of
the instrument. A nitrogen laser with a wavelength of 337 nm then heats the matrix
embedded sample rapidly, causing the sample to vaporize into ions. The ions
subsequently enter the mass spectrometer for identification. [14,15]

Figure 1 Schematic for the preparation of MALDI-TOF MS plate for sample identification. Growth from the
sample culture is applied to target slide and overlaid with matrix. Once dried, it is ready for instrument
anaylsis. (Clark et al., 2013)
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The mass spectrometer used in this assay is Time-of-Flight Mass Spectrometry
(TOF MS). In this stage, charged ions from the vaporized sample are divided based on
their mass-to-charge ratio (m/z). Smaller ions with a greater charge will reach the
detector quicker than larger ions with a smaller charge.

[14]

The detected biomolecules

generate a spectrum that is matched with a database of known organisms. The
matching provides a confidence level which aids in the identification of the sample.

[15]

The detailed steps of the MALDI-TOF MS is presented in Figure 2 below (Croxatto et
al., 2012) . [16]

Figure 2 Identification process via the MALDI-TOF MS system. Matrix-embedded sample is introduced
into a mass spectrometer where a laser strikes the sample resulting in vaporized ions. The ions enter a
flight tube where they are sorted based on mass-to-charge charge ratio (m/z) and read by the detector. A
spectrum is then generated that is matched with a database of known organisms. (Croxatto et al., 2012)
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The Bruker Biotyper system generates a confidence score between 0.00-3.00,
indicating the identification confidence of the organism being analyzed. A score of 2.003.00 (green) indicates a high degree of confidence, 1.70-1.99 (yellow) reflects a low
degree of confidence, and below 1.70 (red) means no identification.
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Results

RapID ANA II System
Research has shown that the accuracy of the RapID ANA II manifested
discrepant results for anaerobic identification. In a performance study conducted by
Marler et al., the RapID ANA II test was thoroughly evaluated for its ability to identity
566 anaerobes. The successful rates of identifying correct species under this method
are summarized in Table 1 below:

Isolate
Gram-negative bacilli
Nonsporeforming gram positive bacilli
Clostridium isolates
Anaerobic cocci

Correct identification (% of total)
62% of 204
70% of 69
74% of 130
72% of 163

Table 1 Identification assessment of 566 anaerobes using the RapID ANA II test, adapted from
“Evaluation of the new RapID-ANA II system for the identification of clinical anaerobic isolates,” Marler et
al., J. Clin. Microbiol. 29: 874-878.

The RapID ANA II kit performed well with spot indole negative Bacteroides
fragilis group, correctly identifying 26 of 28 (93%) isolates. All strains of Parabacteroides
distasonis as well as 19 of 27 (70%) of Bacteroides vulgatus were also accurately
identified. On the contrary, the spot indole positive Bacteroides fragilis group proved
problematic with the RapID ANA II panel. For Bacteroides ovatus and Bacteroides
uniformis, 1 of 29 (3%) and 4 of 14 (29%) were correctly identified, respectively.
Bacteroides ovatus was often confused with Bacteroides uniformis along with
Bacteroides thetaiotaomicron. [9,10] Overall, the RapID ANA II system correctly identified
approximately 68% of the 566 anaerobic isolates to the genus and species level. [9]
The limitations of the RapID ANA II system should be carefully assessed
when using this method in the clinical laboratory. The technologist must ensure that
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pure culture isolates with enough colonies be used to achieve a #3 McFarland standard,
and the RapID ANA II tray be incubated between 4-6 hours at 35-37°C. Setting up the
test outside of the manufacturer’s instructed parameters or using a mixed culture may
lead to misidentification. [8] Additionally, the technologist must have adequate
knowledge of anaerobes to resolve discrepant results as well as sufficient access to
additional tests that may help identify each isolate. Additional tests (including gram
staining, aerotolerance, specimen source, and growth on selective agars) should be
used in conjunction with the RapID ANA II system. [8]

Bruker MALDI-TOF MS System
Numerous studies indicated that Bruker MALDI-TOF MS is a robust platform
which allows users to identify anaerobic organisms with a high level of confidence. In a
study conducted by Schmitt et al. in 2012, this system was evaluated for its capability to
correctly identifying 252 clinical isolates of anaerobic bacteria (see Table 2 below).

Total Isolates
252

Species identification
179 (70.8%)

Genus identification
232 (91.7%)

No identification
20 (7.9%)

Table 2 Evaluation of 252 clinical isolates of anaerobic bacteria using Bruker MALDI-TOF MS, adapted
from “Identification of Anaerobic Bacteria by Bruker Biotyper Matrix-Assisted Laser Desorption and
Ionization-Time of Flight Mass Spectrometry with On-Plate Formic Acid Preparation,” Schmitt et al.,
Journal of Clinical Microbiology,51(3), 782-786.

The anaerobes were identified using Bruker’s cut-off values. A total of 179
(70.8%) and 232 (91.7%) of anaerobic isolates were identified correctly to the genus
and species level using the manufacturers cut-off scores. Twenty (7.9%) of the clinical
isolates had no identification because they received a score below 1.70. [18] This study
demonstrated that using the Bruker Biotyper was a great alternative for identifying
anaerobic bacteria.
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In a subsequent study involving a larger collection of anaerobes for the
evaluation of the Bruker Microflex LT mass spectrometer equipped with the MALDI
Biotyper 3.0 software, the results achieved were even more promising. Barreau et al.,
conducted a study with 1,325 anaerobes to determine the capability of the Bruker MS.
The isolation of anaerobic specimens was from blood culture (362), abscesses and
liquid collection (287), tissue samples (319), osteo-articular samples (144), sinus
samples (115), lymph nodes (21), cerebral spinal fluid (20), pleural samples (32) and
other samples (25). [19] The Bruker MS correctly identified 92.5% of isolates to the
species level and 98.9% identified to genus level. 14 of the 1325 samples could not be
identified to the genus level. [19] Table 3 below summarizes the findings from the study.
Barreau et al. stated that the improvements in identification were due to software
upgrades. Barreau et al. further pointed out that this method should be considered the
new gold standard for the routine identification of clinical anaerobes.

Total Isolates
1,325

Species
identification
(score ≥ 1.9)
1,225 (92.5%)

Genus identification
(score <1.9 ≥ 1.7)
86 (6.5% genus only)

No identification
(Score < 1.7)
14 (1.0%)

Table 3 Evaluation of the Bruker MALDI-TOF MS with Biotyper 3.0 software for the identification of 1,325
anaerobic isolates, adapted from “Improving the identification of anaerobes in the clinical microbiology
laboratory through MALDI-TOF mass spectrometry,” by Barreau et al., 2013, Anaerobe 22, 123-125.
Copyright by 2013 Elsevier Ltd.

The MALDI-TOF MS must be validated to ensure it produces reliable and
reproducible results before implementing it within the clinical laboratory. To properly
validate this platform, the laboratory must follow the regulatory guidelines established by
the College of American Pathologists (CAP) and the Clinical Laboratory Improvement
Amendments (CLIA) for method validation.
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According to CAP All Common Checklist, a minimum of 20 samples should be
tested. [20,21] Likewise, CLIA suggests a minimum of 20 samples to be run for method
validation. However, majority of other sources suggest running at least 40 specimens to
detect discrepancies. Ideally speaking, method validation should be performed over a
period of five days with a confidence score of at least 90%. However, if discrepancies
are observed, the validation should be extended for five more days. [22]
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Discussion
Cost effectiveness is a key consideration when incorporating a new platform in
the clinical laboratory. The new method should yield a positive return of investment,
allowing resources and personnel to be allocated elsewhere in the department for
quality improvements. When comparing the two platforms discussed earlier (see Table
4 below), the cost per test and versatility of each method should be carefully analyzed.

Turnaround time
Accuracy
Cost

RapID ANA II
4-6 hours
68% to genus and species
$9.19/test

Bruker MALDI-TOF MS
~15 minutes
92.5% to genus and species
$0.50/test

Table 4 Comparison of the RapID ANA II and Bruker MALDI-TOF MS based on turnaround time,
accuracy, and cost-effectiveness.

The Department of Veteran Affairs lists a 20 pack RapID ANA II kit for the price
of $152.16. [23] The kit includes the ANA II reagent but does not include the spot indole
or RapID inoculation fluid that must be purchased separately. The rapid spot indole
reagent is listed for $11.12, and the RapID inoculation fluid costs $20.43 for a pack of
20. [23] The price of the Bruker MALDI-TOF MS costs $150,000. [24] In addition, the
Bruker requires additional consumables to run a sample. The consumables required to
operate the MALDI TOF MS are pipette tips, target slides, matrix, and formic acid.
When we factor in the RapID ANA II kit with the spot indole reagent, the cost is $9.19
per test. Using the MALDI-TOF MS; however, only costs $0.50 per test with a much
higher level of accuracy in identification (92.5% with Bruker vs. 68% with RapID)

[24,25]

This data shows that the clinical laboratory could run 18 anaerobe samples with
MALDI-TOF MS for the cost of running one sample with RAPID ANA II. In addition, the
test under RapID ANA II requires the kit to be incubated for 4 hours, applying reagents,
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interpreting of each enzymatic test, and entering enzyme results into the ERIC database
for identification. In contrast, the MALDI-TOF MS can identify a sample in approximately
15 minutes. [25]
The savings of incorporating MALDI-TOF MS are more profound than what have
been discussed earlier. In a study conducted in a Taiwanese laboratory from July to
December 2012, 52,500 isolates were analyzed (47,300 aerobes and 5,200
anaerobes). This study revealed a bi-annual savings of $84,000 compared to
conventional biochemical methods. [26] If the 5,200 anaerobes were to be identified
using RapID ANA, it would cost $42,284 compared to $2,600 using the MALDI-TOF
Apparently, MALDI-TOF MS is much more versatile than RapID because the former
could also identify yeast and aerobic organisms; thereby, significantly improving the
financial health of the entire laboratory.
In a study conducted by the University of North Carolina Hospitals from April
2013 to March 2014, using MALDI-TOF MS could realize an annual savings of $73,646,
which would compensate for the cost of the equipment within 3 years. [27] Nevertheless,
cost savings also depend on the volume received at each laboratory, with larger
institutions being able to offset the cost of the instrument much quicker.
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Conclusion
The Bruker MALDI-TOF MS provides a more robust platform for identifying
anaerobes within the clinical laboratory due to the following factors:
•

Identification of anaerobes can be efficiently accomplished within 15 minutes since it
does not require an aerotolerance test. The quicker turnaround time allows clinicians
to treat patients more effectively and reduce the duration of hospital visits. In
contrast, the RapID ANA II method recommends a 24-hour aerotolerance test and
an additional 4-6 hours of incubation for identification.

•

MALDI-TOF MS offers 18 times more savings than RapID ANA II, costing $0.50
compared to $9.19 per test and with a much higher successful rate in identification.

•

Bruker’s database of organism continues to expand through software upgrades,
which allows for the timely detection of anaerobic organisms with increased
accuracy.

•

Numerous studies have shown that MALDI-TOF MS is more sensitive and specific
than conventional methods for identifying anaerobes.
In conclusion, MALDI-TOF MS has emerged as a superior method of

identification over the RapID ANA II system within the clinical laboratory. The advent of
MALDI-TOF MS has demonstrated increased specificity, cost-effectiveness, and
decreased turnaround time. Due to the infancy of MALDI-TOF MS, it may require an
alternative method of identification for confirmation, such as 16S RNA and WGS
sequencing. However, research has proven the MALDI-TOF MS is capable of
continuous improvements through a growing database. The MALDI-TOF MS has
flourished in the clinical laboratory for the routine identification of anaerobes.
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Isolates
Actinobacteria (417)
Propionibacterium (375)
Atopobium (7)
Bifidobacterium (8)
Eggerthella (10)
Slackia exigua (12)
Actinobaculum (4)
Brevibacterium frigotolerans (1)
Clostridiales (343)
Anaerotruncus colihominis (1)
Finegoldia (98)
Peptostreptococcus (9)
Anaerococcus (32)
Parvimonas (82)
Peptoniphilus (66)
Clostridium (43)
Tissierella praeacuta (1)
Bilophila wadsworthia (3)
Dialister microaerophilus (2)
Eubacterium (3)
Ruminococcus gnavus (2)
Lactobacillus (12)
Fusobacterium (86)
Bacteriodales (442)
Porphyromonas (17)
Bacteroides (299)
Parabacteroides (11)
Prevotella (80)
Veillonella (29)
Alistipes finegoldii (1)
Butyricimonas (4)
Odoribacter splanchnicus (1)
Erysipelotrichales (9)
Solobacterium moorei (8)
Turicibacter sanguinis (1)
Proteobacteria (2)
Desulfovibrio (2)
Overall (1311)

Species identification

Genus identification

(score ≥ 1.9)

(score < 1.9 ≥ 1.7)

387 (92.3%)
350 (96.9%)
7 (100%)
6 (75%)
8 (80%)
12 (100%)
3 (75%)
1 (100%)
314 (90.8%)
1 (100%)
86 (86.1%)
9 (90%)
24 (66.7%)
77 (93.5%)
65 (98.5%)
41 (95.1%)
1 (100%)
3 (100%)
2 (100%)
3 (100%)
2
12 (100%)
76 (86.9%)
425 (96%)
14 (78.6%)
292 (97.6%)
11 (100%)
74 (91.9%)
29 (100%)
1 (100%)
3 (75%)
1 (100%)
9 (100%)
8
1
2 (100%)
2 (100%)
1225 (92.5%)

30 (7.7%)
25 (7.1%)
2 (15%)
2 (20%)
1 (25%)
29 (9.2%)
12 (13.9%)
1 (10%)
8 (33.3%)
5 (6.5%)
1 (1.5%)
2 (4.9%)

10 (13.1%)
17 (4%)
3 (21.4%)
7 (2.4%)
6 (8.1%)

1 (25%)

86 (6.5%)

Table 5 Identification of 1,311anaerobe isolates at the genus and species level using the Bruker MALDITOF MS, adapted from “Improving the identification of anaerobes in the clinical microbiology laboratory
through MALDI-TOF mass spectrometry,” by Barreau et al., 2013, Anaerobe 22, 123-125. Copyright by
2013 Elsevier Ltd.
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